GlassScriptPhysician profile
Buffie M Hendrix
NPI 1760900336
$2,562.81
in general payments reported to CMS, 2019-2025
14 companies · $572 in 2025
The $572 reported for 2025 was more than what 76% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $264 · 2022: $220 · 2023: $1,118 · 2024: $389 · 2025: $572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,134 · Travel and Lodging: $936 · Education: $9.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,134.12 |
| Travel and Lodging | $935.56 |
| Education | $9.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,158.13 | 2023-2025 | Corevalve Evolut R, Micra |
| Novartis Pharmaceuticals Corporation | $380.64 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $241.05 | 2022-2025 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $206.90 | 2022-2025 | Lifevest |
| Amgen INC. | $181.87 | 2021-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $130.49 | 2025 | Watchman Flx |
| E.R. Squibb & Sons, L.L.C. | $94.79 | 2022-2025 | Eliquis, Camzyos |
| Merck Sharp & Dohme LLC | $43.72 | 2024-2025 | Verquvo |
| Impulse Dynamics (USA) INC. | $32.14 | 2025 | Optimizer |
| Pfizer INC. | $28.04 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.61 | 2025 | |
| Janssen Pharmaceuticals, INC | $16.51 | 2022 | |
| Novo Nordisk INC | $16.06 | 2025 | Wegovy |
| Irhythm Technologies, INC. | $14.86 | 2024 | Zio Xt Patch, Zio Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Buffie Hendrix listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.